IIT Madras Partners With IRFC To Establish Nation’s First Single Cell Omics Translational Research Lab
Chennai: The Indian Institute of Technology Madras (IIT Madras) has recently partnered with the Indian Railways Finance Corporation (IRFC), a Navratna Public Sector Enterprise, to establish the nation’s first ‘Single Cell Omics Translational (SCOT) Research Laboratory’. This significant initiative aims to advance India’s precision healthcare ecosystem by bridging the fields of engineering and medicine.
Inauguration of the SCOT Lab
The SCOT Lab was inaugurated on the IIT Madras campus, marking a pioneering step towards enhancing public health through advanced research capabilities. The laboratory is equipped with state-of-the-art instrumentation that will facilitate early diagnosis, disease prognosis, biomarker discovery, and drug screening across a wide range of diseases, including:
- Cancer
- Cardiovascular diseases
- Infectious diseases
- Inflammatory diseases
- Metabolic disorders
- Other non-communicable diseases
Funding and Support
IRFC has generously provided a Corporate Social Responsibility (CSR) grant of Rs 10.83 crore to establish the lab, which is located within the Department of Medical Sciences and Technology (DMST) at IIT Madras. This funding is aimed at accelerating research in single-cell biology, drug discovery, biomarker identification, and translational healthcare innovation.
Key Dignitaries at the Launch
The launch event was attended by several dignitaries, including:
- Prof V. Kamakoti – Director, IIT Madras
- Usha Venugopal – Member (Finance), Ministry of Railways
- Manoj Kumar Dubey – Chairman and Managing Director, IRFC
- Prof Ashwin Mahalingam – Dean (Alumni and Corporate Relations), IIT Madras
- Prof Boby George – Head, DMST, IIT Madras
- Prof Krishna Kumar – DMST, IIT Madras
- Prof Anubama Rajan – DMST, IIT Madras
Significance of the SCOT Lab
During the inauguration, Prof Kamakoti emphasized the importance of such facilities in driving the ‘Make in India’ initiative in critical fields like healthcare. He stated, “Our collaboration with IRFC marks an important milestone in accelerating India’s journey in drug discovery and precision medicine. IIT Madras has been at the forefront of integrating engineering and medical sciences, and the state-of-the-art SCOT research laboratory will greatly enhance our ability to develop solutions for India’s capabilities in early diagnostics, targeted therapeutics, and next-generation healthcare innovation.”
Future Prospects
Usha Venugopal expressed optimism about the lab’s potential impact on medical research, saying, “The inauguration of the SCOT research lab is a welcome step toward building stronger capabilities in medical research. The support extended through IRFC’s CSR funding will aid studies that have the potential to improve early diagnosis and develop better therapies. This collaboration shows how institutions can work together for larger national goals.”
The partnership between IRFC and IIT Madras represents a transformative step toward decoding diseases at an unprecedented cellular level, paving the way for personalized treatment strategies and next-generation therapeutics. Prof Rajan noted the necessity for research platforms that connect molecular insights directly to clinical impact, stating, “With the SCOT research laboratory established in partnership with IRFC, we now have the capability to study diseases at single-cell resolution, accelerate drug discovery, and develop early-detection and precision-medicine strategies tailored to our patients.”
IRFC’s Commitment to Healthcare Innovation
Manoj Kumar Dubey, Chairman and Managing Director of IRFC, expressed pride in the partnership, saying, “IRFC is proud to partner with IIT Madras in establishing the pioneering Single Cell Omics Translational Research Laboratory. Our CSR contribution of Rs 10 crore reflects IRFC’s commitment to fostering cutting-edge research and strengthening India’s healthcare innovation ecosystem.”
Conclusion
The establishment of the SCOT Lab at IIT Madras is a significant milestone in India’s healthcare landscape, promising advancements in early diagnosis, targeted therapies, and overall health outcomes. This collaboration not only highlights the importance of interdisciplinary research but also sets a precedent for future partnerships aimed at improving public health through innovative scientific exploration.
Note: The information presented in this article is based on the latest available data as of November 2025.
